Lars wrote:I didn't know we we ever going to be unblinded. What does that mean for us exactly? Access to our 11b data? MRI's? drug vs placebo? By the way does anyone know when/if phase 111 begins recruiting.
We'll at least know if we had placebo or the real gunk. Now about Phase III, I seem to remember that Opexa launched US pretty much after it wrapped up Phase I... but I can't remember if that involved publication or just getting the nod from the FDA to "carry on."
I suspect Phase III-ers will be off and running shortly after we conclude our two years. Probably the beginning of '10?
If our results come back dazzling and Phase III lives up to expectations, I really think the FDA will fast-track Tovaxin before the two-year protocol finishes for "them thar guys."
We have only to read other MS message boards to realize that getting our stuff to market is soooo important.